Page last updated: 2024-08-24

ginkgolide b and Angiogenesis, Pathologic

ginkgolide b has been researched along with Angiogenesis, Pathologic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, J; Han, Y; Hu, J; Jin, Z; Kong, L; Luo, J; Yang, L; Yu, P; Zhang, C; Zhao, C; Zhu, J1
He, X; He, Z; Hu, J; Ke, J; Lan, P; Li, S; Lian, L; Sun, L; Wu, X; Zou, Y1
Chen, XH; Liao, WH; Ou-Yang, XY; Wang, WJ1

Other Studies

3 other study(ies) available for ginkgolide b and Angiogenesis, Pathologic

ArticleYear
Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
    Pharmacological research, 2022, Volume: 180

    Topics: Animals; Brain Ischemia; Creatine Kinase; Endothelial Cells; Ginkgolides; Infarction, Middle Cerebral Artery; Ischemic Stroke; Lactones; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Stroke

2022
PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:1

    Topics: Animals; Azoxymethane; Carcinogenesis; Colitis; Dextran Sulfate; Female; Ginkgolides; Lactones; Mice; Neovascularization, Pathologic; Plant Extracts; Platelet Activating Factor

2015
[Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:4

    Topics: Animals; Cell Line; Diterpenes; Female; Fibrinolytic Agents; Fibroblasts; Ginkgolides; Granuloma; Humans; Inflammation; Interleukin-1; Lactones; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha; U937 Cells

2005